Skip to content

Multicenter retrospective study to confirm the efficacy and safety of carbon ion radiotherapy for choroidal malignant melanoma

Multicenter retrospective study to confirm the efficacy and safety of carbon ion radiotherapy for choroidal malignant melanoma - Multicenter retrospective study to confirm the efficacy and safety of carbon ion radiotherapy for choroidal malignant melanoma

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
JPRN
Registry ID
JPRN-UMIN000060481
Enrollment
350
Registered
2026-01-27
Start date
2026-01-27
Completion date
Unknown
Last updated
2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

choroidal malignant melanoma

Interventions

None listed

Sponsors

National Institutes for Quantum Science and Technology (QST)
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: Patients who received carbon ion radiotherapy for choroidal malignant melanoma at QST Hospital from April 2001 to March 2024.

Exclusion criteria

Exclusion criteria: Cases in which the secondary use of clinical data is refused when obtaining consent for treatment or other research, and cases in which the research subject or his/her representative refuses the use of clinical data in this study.

Design outcomes

Primary

MeasureTime frame
overall survival

Countries

Japan

Contacts

Public ContactMasaru Wakatsuki

National Institutes for Quantum Science and Technology Dept. of Treatment and diagnosis

wakatsuki.masaru@qst.go.jp0432063306

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026